2024 ASBMB Election

COLE, Philip

Professor, Harvard Medical School, Departments of Medicine and Biological Chemistry and Molecular Pharmacology


Philip Cole

Statement of interest

I believe that the ASBMB has an important mission in promoting research in mechanistic biology and investigation at the chemistry–biology interface. Through its journals, conferences and policy advocacy, the ASBMB has historically been at the forefront in fostering rigorous and impactful science, education and training and professional development.

The ASBMB is known for standing for the values of scientific excellence as well as diversity, equity and inclusion. I embrace the ASBMB mission and values and would be proud to be part of the ASBMB Council in service of these goals.

I am concerned about the threats faced by science and scientists, including the loss of public confidence in biomedical science, reduction in financial support for research and the spread of false information. As a member of the ASBMB Council, I would view my role and responsibility as helping to promote enlightened, empathetic and inclusive approaches for disseminating evidence-based scienctific policy and practices for the betterment of our society, locally and globally.

Education and training

  • B.S., Chemistry, Yale University, 1984
  • Churchill Scholar, University of Cambridge, United Kingdom, 1984–1985
  • MD./Ph.D., Bioorganic Chemistry, Johns Hopkins University, 1991
  • Postdoctoral training, Harvard Medical School and Brigham and Women’s Hospital, 1996

Awards and honors

  • Damon–Runyon Scholar Award, 1997
  • Burroughs Wellcome New Investigator Award in Toxicology, 1998
  • Maryland Daily Record Top Innovator of the Year, 2006
  • Elected member, American Society for Clinical Investigation, 2006
  • Fellow, American Association for the Advancement of Science, 2013
  • MERIT Award, National Institutes of Health, 2013
  • William Stein lecturer, Rockefeller University, 2017
  • Abbvie lecturer, University of California, Berkeley, 2017
  • Sterling lecturer, Boston University, 2021
  • T.T. Tchen lecture, Wayne State University, 2023


  • Assistant professor and lab head, Rockefeller University, 1996–1999
  • Professor and director, Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, 1999–2017
  • Editorial board member, Bioorganic Chemistry, 2002–present
  • Consultant, Memorial Sloan Kettering Cancer Center Board of Scientific Consultants, 2002–present
  • Editorial board member, Biomed Central–Biology, 2003–present
  • Member, SBCB NIH Study Section, 2008–2012
  • Co-chair, Gordon Research Conference on Enzymes, Coenzymes, Metabolic Pathways, 2009
  • Chair, SBCB National Institutes of Health Study Section, 2010–2012
  • Co-founder and adviser, Acylin Therapeutics, 2010–2014
  • Chair, Memorial Sloan Kettering Cancer Center Board of Scientific Consultants, 2010–2020
  • Editorial board member, ChemBioChem, 2010–current
  • Editorial board member, eLife, 2012–2022
  • Advisory board member, Maryland Institute of Basic Biomedical Research, 2014–2020
  • Editorial board member, Journal of Biological Chemistry, 2016–2022
  • Advisory board member, Searle Scholars Program, 2016–2023
  • Professor of medicine and BCMP, Harvard Medical School, 2017–present
  • Organizer, FASEB Conference on Reversible Acetylation, 2018–2019
  • Interim chief, Division of Genetics, Brigham and Women’s Hospital, 2022–present
  • Associate editor, Journal of Biological Chemistry, 2022–present
  • Co-director, Harvard Chemical Biology Ph.D. program, 2023–present